Breaking News, Collaborations & Alliances

Frontier Medicines Advances First Target Under Abbvie Alliance

Continues to advance its ongoing efforts and strategic focus on difficult-to-drug protein targets.

Author Image

By: Charlie Sternberg

Associate Editor

Frontier Medicines Corporation, a precision medicine company seeking to unlock the proteome to advance breakthroughs against otherwise undruggable disease-causing targets, has announced the first target for the development of a small molecule inhibitor is advancing into the lead generation phase under the company’s global partnership with AbbVie.   The global partnership was established in December 2020 to discover, develop, and commercialize a pipeline of innovative small molecule therapeutic...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters